FDA risk management “toolkit” meeting
Executive Summary
FDA plans to hold a public hearing on drug risk management tools in May. FDA and the Pharmaceutical Research & Manufacturers of America met privately in October and November to begin developing risk management "toolkit" options (1"The Pink Sheet" Dec. 17, 2001, p. 28)...